SENESCEA
LIVE

Serial Number

97577353

Owner

SENESCEA THERAPEUTICS, INC.

Attorney

Jared M. Barrett

Filing Date

Sep 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SENESCEA Trademark

Serial Number: 97577353

SENESCEA is a trademark filed by SENESCEA THERAPEUTICS, INC. on September 2, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

SENESCEA THERAPEUTICS, INC. (2 trademarks)

12278 Scripps Summit Drive
San Diego, CA 92131

Entity Type: 03

Trademark Details

Filing Date

September 2, 2022

Registration Date

Not Registered

Published for Opposition

May 7, 2024

Goods & Services

Pharmaceutical and therapeutic agents for use in cellular regeneration and cellular rejuvenation; pharmaceutical and therapeutic agents for the treatment of age-related diseases, and the treatment of degenerative diseases; pharmaceutical and therapeutic agents for use in targeting or regulating senescent cells; pharmaceutical and therapeutic agents designed to directly target and regulate senescent cells for cellular regeneration, cellular rejuvenation to restore cell health, treatment of age-related diseases, treatment of degenerative diseases, anti-aging treatments, treatments to reverse human disease, and treatment of human disease; cells for regenerative medicine for the treatment of age-related diseases, treatment of degenerative diseases, anti-aging, to reverse human disease, and to directly target and regulate senescent cells; clinical medical reagents

medical and medical clinical research and development for others in the field of cellular rejuvenation; medical and scientific research, namely, conducting preclinical research and clinical trials

providing health and medical information; providing a website featuring health and medical information

reagents for research purposes for drug discovery and development; Diagnostic reagents for clinical or medical laboratory use

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 19, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 18, 2025 EX3G
SOU EXTENSION 3 FILED
Dec 18, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 18, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jun 17, 2025 EX2G
SOU EXTENSION 2 FILED
Jun 17, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 17, 2024 EX1G
SOU EXTENSION 1 FILED
Dec 17, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 16, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 2, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 2, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 11, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 9, 2024 GNFN
FINAL REFUSAL E-MAILED
Jan 9, 2024 GNFR
FINAL REFUSAL WRITTEN
Jan 9, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 3, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 3, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 3, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 3, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 3, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 19, 2023 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Oct 24, 2022 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Oct 24, 2022 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 21, 2022 NWOS
NEW APPLICATION ENTERED
Sep 6, 2022 NWAP